The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReneuron Share News (RENE)

  • This share is currently suspended. It was suspended at a price of 3.275

Share Price Information for Reneuron (RENE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.275
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3.275
RENE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Cadence rises on Amapa "landmark"; ASOS dives

Mon, 11th Oct 2021 10:59

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

----------

AIM - WINNERS

----------

Cadence Minerals PLC, up 42% at 24.65 pence, 12-month range 11.1p-32.49p. Receives confirmation from its secured bank creditors that they have obtained approval from their credit committees for the proposed terms of a settlement agreement, paving the way for Cadence to vest an initial 20% in the Amapa iron ore project in Brazil. A joint venture between Cadence and Indo Sino Trade Pte Ltd will own 99.9% of DEV Mineracao SA, the owner of the Amapa project. "Today's announcement is a landmark for Amapa, both in terms of certainty for DEV employees, the wider Amapa community and for Cadence shareholders," says Chair Andrew Suckling.

----------

Reneuron Group PLC, up 31% at 123.80p, 12-month 70p-153.78p. The biotechnology company reports positive data that provides "clear pre-clinical proof-of-concept" that its novel exosome drug delivery technology can effectively deliver therapeutic proteins to the specific region of the brain affected by several neurological diseases. "These results are a key milestone for our exosome delivery technology, establishing clear proof of concept in vivo, which more accurately imitates conditions for the targeted delivery of key neurological therapeutics into the human brain," says Chief Executive Olav Hellebo.

----------

Feedback PLC, up 16% at 0.8432p, 12-month range 0.6p-1.57p. The medical imaging software company signs memorandum of understanding with Quest Teleradiology Solutions - a teleradiology organisation with customers across India, the UK and throughout Africa - to develop strategic opportunities for Bleepa, its clinical communications platform, in the "large and growing" Indian healthcare market, the UK and internationally.

----------

Oracle Power PLC, up 15% at 0.385p, 12-month 0.3p-0.75p. The natural resources project developer signs non-exclusive co-operation agreement with PowerChina International Group Ltd to jointly develop a green hydrogen production facility in Pakistan. It is targeting 400 megawatt capacity hydrogen plant, with planned output of around 150,000 kilograms per day.

----------

AIM - LOSERS

----------

ASOS PLC, down 11% at 2,474p, 12-month range 2,300p-5,994.95p. The online fashion retailer posts jump in annual profit, but warns on year ahead and announces departure of chief executive. Adjusted pretax profit for the 2022 financial year expected between around GBP110 million to GBP140 million. This is well below the GBP193.6 million registered for the financial year just ended. ASOS shakes up board to "underpin delivery of the next phase of its global growth strategy". CEO Nick Beighton is stepping down after 12 years with ASOS, including six as CEO, and a search is underway for his replacement.

----------

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
23 Feb 2016 16:05

ReNeuron moving to purpose-built labs in Wales

(ShareCast News) - ReNeuron's office, laboratory and manufacturing staff were preparing for a space upgrade this week, with the firm announcing it was moving from Guildford to Pencoed in South Wales. The AIM-traded stem cell therapy development company said the new location was purpose-built, and wo

Read more
23 Feb 2016 09:16

ReNeuron Relocating Headquarters To South Wales Business Park

Read more
3 Feb 2016 15:15

Babcock non-exec picks up some shares

(ShareCast News) - Engineering support services company Babcock International said non-executive director Jeff Randall purchased 1,134 shares at 8.81p each. This brings his total holding to 4,268 shares. On Tuesday, Babcock said its joint venture with Lockheed Martin, Ascent Flight Training, had

Read more
3 Feb 2016 11:18

DIRECTOR DEALINGS: ReNeuron Group Chairman Ups Interest

Read more
1 Feb 2016 09:15

ReNeuron Gets Notice Of Grant For US Cell Cryopreservation Patent

Read more
12 Jan 2016 10:06

ReNeuron Greets Exosome Nanomedicine Data Publication In Journal

Read more
11 Jan 2016 08:07

ReNeuron Group Wins UK Grant For Its Exosome Nanomedicine Platform

Read more
7 Dec 2015 09:30

ReNeuron First Half Loss Widens As It Progresses Clinical Development

Read more
4 Dec 2015 09:15

ReNeuron Group Appoints Ex-Glaxo Executive Owen To Board

Read more
24 Sep 2015 10:39

ReNeuron Says Fundraising Will Allow It To Develop Clinical Pipeline (ALLISS)

Read more
17 Sep 2015 15:09

AGM, EGM Calendar - Week Ahead

Read more
21 Aug 2015 07:29

LONDON BRIEFING: China And Greece Combine To Send Stocks Reeling

Read more
21 Aug 2015 05:17

AGM, EGM Calendar - Week Ahead

Read more
20 Aug 2015 15:14

AGM, EGM Calendar - Week Ahead

Read more
20 Aug 2015 05:19

AGM, EGM Calendar - Week Ahead

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.